Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. April 2024 08:05 ET | Quelle: Shareholder Capital LLC

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
23. März 2021 07:15 ET | Quelle: Shareholders Foundation, Inc.

NASDAQ: VNDA Investor Notice: Update in Lawsuit against Vanda Pharmaceuticals Inc. announced by Shareholders Foundation

SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). ...
24. Februar 2021 10:05 ET | Quelle: PMI

Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI

Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
11. Februar 2019 10:49 ET | Quelle: Block & Leviton LLP

Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...